The Edge Daily from Malaysia gives a summary of an interview Li Ka-shing, China's richest man, gave to Forbes Asia.
Li Ka-shing invites foreign pharmaceutical companies to partner up with him to integrate low production costs in China with the quality control of Western medicine to tap the huge demand in China. Li said in the interview according to The Edge that China needed to put more resources into protecting intellectual property to prevent imitation drugs:
“Without IP rights, there would be no new technology developed, but China needs time and resources to set up a watchdog bureau. IP offenders must be brought to justice, even if you have pay $1.10 in legal fees to recover $1 of loss.”
And if Superman, as Li Ka-shing is called in Hong Kong, says such things, enforcing IPR at a loss in individual cases to enhance the investment climate at large, people listen, also on the Mainland.
Read The Edge Daily article here.
Update: I found the original article 'Thoughts of Chairman Li' which is a very good read, by Vivian Kwok Wai Yin and Tim W. Ferguson for Forbes Asia, here.
continue reading ...
Li Ka-shing invites foreign pharmaceutical companies to partner up with him to integrate low production costs in China with the quality control of Western medicine to tap the huge demand in China. Li said in the interview according to The Edge that China needed to put more resources into protecting intellectual property to prevent imitation drugs:
“Without IP rights, there would be no new technology developed, but China needs time and resources to set up a watchdog bureau. IP offenders must be brought to justice, even if you have pay $1.10 in legal fees to recover $1 of loss.”
And if Superman, as Li Ka-shing is called in Hong Kong, says such things, enforcing IPR at a loss in individual cases to enhance the investment climate at large, people listen, also on the Mainland.
Read The Edge Daily article here.
Update: I found the original article 'Thoughts of Chairman Li' which is a very good read, by Vivian Kwok Wai Yin and Tim W. Ferguson for Forbes Asia, here.
